Emerging indications (MASH, neuroprotection, seizure modulation, cravings, fertility/PCOS, pulmonary outcomes) expand the therapeutic horizon, while future pipelines (oral GLP-1s, triple agonists, amylin co-agonists) promise refined personalization and access
Chronic hypoxia due to residence at high altitudes also induces changes in the placental vasculature by increasing placental capillary density with decreased remodeling (Tissot van Patot et al., 2003)
Medicare GLP-1 Bridge Launching July 1, 2026, the Bridge offers eligible Medicare beneficiaries Wegovy for weight loss at $50 per month through December 31, 2027, outside the Part D benefit
In another study, it has been confirmed that treatment of AR mice with caffeoylxanthiazonoside-coated gold nanoparticles reduced the IFN- and IL-4 levels in nasal lavage fluid
I can't say enough good about Maria